MedTrace Logo

A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors

NCT07449195 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-05-13

No results posted yet for this study

Summary

The purpose of this study is to compare two devices used for optical coherence tomography (OCT). OCT is a noninvasive imaging (scanning) method that uses reflected light to create pictures of the back of the eye, and doctors can use OCT to detect and monitor different types of cancer

Conditions

  • Ocular Tumor

Interventions

DIAGNOSTIC_TEST

Intalight Dream OCT

This is a next-generation swept-source device that has a faster imaging speed and higher sensitivity than the previous generation of frequency-domain OCT devices, which serve as the current standard of care devices.

DIAGNOSTIC_TEST

Heidelberg Spectralis OCT

This is the standard of care for optical imaging.

Sponsors & Collaborators

Principal Investigators

  • Jasmine Francis, MD · Memorial Sloan Kettering Cancer Center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-27
Primary Completion
2028-02-27
Completion
2028-02-27

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07449195 on ClinicalTrials.gov